CN1188138C - 精制海狗油在制备防治更年期综合症药中的应用 - Google Patents
精制海狗油在制备防治更年期综合症药中的应用 Download PDFInfo
- Publication number
- CN1188138C CN1188138C CNB03121066XA CN03121066A CN1188138C CN 1188138 C CN1188138 C CN 1188138C CN B03121066X A CNB03121066X A CN B03121066XA CN 03121066 A CN03121066 A CN 03121066A CN 1188138 C CN1188138 C CN 1188138C
- Authority
- CN
- China
- Prior art keywords
- acid
- omega3
- refined
- fatty acid
- seal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 6
- 230000003405 preventing effect Effects 0.000 title abstract description 4
- 208000011580 syndromic disease Diseases 0.000 claims abstract description 17
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 17
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims abstract description 16
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 16
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 16
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 9
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 9
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002253 acid Substances 0.000 claims abstract description 4
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 claims abstract description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229940031439 squalene Drugs 0.000 claims abstract description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 3
- 229940046009 vitamin E Drugs 0.000 claims abstract description 3
- 239000011709 vitamin E Substances 0.000 claims abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 10
- 229930195729 fatty acid Natural products 0.000 claims description 10
- 239000000194 fatty acid Substances 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 6
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 235000021290 n-3 DPA Nutrition 0.000 claims description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 13
- 229910052799 carbon Inorganic materials 0.000 abstract description 7
- 210000003754 fetus Anatomy 0.000 abstract description 7
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- -1 docosa-carbon pentaene Chemical compound 0.000 abstract description 2
- DQGMPXYVZZCNDQ-KBPWROHVSA-N (8E,10E,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C=C/C=C/CCCCCCC(O)=O DQGMPXYVZZCNDQ-KBPWROHVSA-N 0.000 abstract 1
- DQGMPXYVZZCNDQ-UVZPLDOLSA-N Calendinsaeure Natural products CCCCCC=C/C=C/C=C/CCCCCCC(=O)O DQGMPXYVZZCNDQ-UVZPLDOLSA-N 0.000 abstract 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 abstract 1
- 210000004720 cerebrum Anatomy 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 150000004671 saturated fatty acids Chemical class 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 238000007670 refining Methods 0.000 description 26
- 241001465754 Metazoa Species 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 230000037396 body weight Effects 0.000 description 15
- 208000005171 Dysmenorrhea Diseases 0.000 description 11
- 241000700159 Rattus Species 0.000 description 11
- 150000003180 prostaglandins Chemical class 0.000 description 11
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 241000283216 Phocidae Species 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- YUFFSWGQGVEMMI-UHFFFAOYSA-N (7Z,10Z,13Z,16Z,19Z)-7,10,13,16,19-docosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCCCC(O)=O YUFFSWGQGVEMMI-UHFFFAOYSA-N 0.000 description 6
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 6
- 238000010171 animal model Methods 0.000 description 6
- 238000009534 blood test Methods 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- XIVFQYWMMJWUCD-UHFFFAOYSA-N dihydrophaseic acid Natural products C1C(O)CC2(C)OCC1(C)C2(O)C=CC(C)=CC(O)=O XIVFQYWMMJWUCD-UHFFFAOYSA-N 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 235000021323 fish oil Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 230000037182 bone density Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 4
- 229960002986 dinoprostone Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000002266 menstruation inducing agent Substances 0.000 description 4
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000005186 women's health Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000001198 duodenum Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000009245 menopause Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- CBOMORHDRONZRN-QLOYDKTKSA-N prostaglandin E3 Chemical compound CC\C=C/C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O CBOMORHDRONZRN-QLOYDKTKSA-N 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 230000008175 fetal development Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010049669 Dyscalculia Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000024783 anasarca Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 210000003459 common hepatic duct Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002356 skeleton Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
项目 | 指标 |
水分及挥发物,% ≤ | 0.2 |
酸价,mgKOH/g ≤ | 2.0 |
过氧化值,meq/Kg ≤ | 6.0 |
杂质,% ≤ | 0.1 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB03121066XA CN1188138C (zh) | 2003-03-24 | 2003-03-24 | 精制海狗油在制备防治更年期综合症药中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB03121066XA CN1188138C (zh) | 2003-03-24 | 2003-03-24 | 精制海狗油在制备防治更年期综合症药中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1437955A CN1437955A (zh) | 2003-08-27 |
CN1188138C true CN1188138C (zh) | 2005-02-09 |
Family
ID=27674251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB03121066XA Expired - Fee Related CN1188138C (zh) | 2003-03-24 | 2003-03-24 | 精制海狗油在制备防治更年期综合症药中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1188138C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104082752A (zh) * | 2014-06-29 | 2014-10-08 | 宁波市成大机械研究所 | 一种含有角鲨烯的海狗油软胶囊 |
-
2003
- 2003-03-24 CN CNB03121066XA patent/CN1188138C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1437955A (zh) | 2003-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103687500B (zh) | 专门设计的脂质组分的代谢印迹效应 | |
CN1468059A (zh) | 油/脂组合物 | |
CN1468061A (zh) | 油/脂组合物 | |
CN1179026C (zh) | 油脂组合物 | |
CN101473953A (zh) | 净血排毒组合食品及其加工方法和应用 | |
CN1468060A (zh) | 油/脂组合物 | |
CN1326344A (zh) | Pufa增补剂 | |
CN103190619A (zh) | 一种鱼油亚麻籽油软胶囊及其制备方法 | |
JP6387371B2 (ja) | メタボリックシンドローム改善剤 | |
TW200744573A (en) | Use of dha and ara in the preparation of a composition for preventing or treating obesity | |
CN112941121A (zh) | 抗肿瘤生长、抑制癌细胞迁移的脂肪酸结构脂质的制备方法 | |
CN101062025A (zh) | 用于减肥、降脂、降糖、降压、防治骨质疏松的复方制剂 | |
WO2011080982A1 (ja) | うつ病又はうつ状態の予防又は治療用油脂組成物 | |
CN1188138C (zh) | 精制海狗油在制备防治更年期综合症药中的应用 | |
CN1114878A (zh) | 一种防治心血管系统疾病的制剂 | |
KR100793645B1 (ko) | 기능성 사료첨가제 | |
JP2004075653A (ja) | 体脂肪分解促進剤および飲食物 | |
JPWO2004022049A1 (ja) | 痩身剤およびその飲食物 | |
CN1108111C (zh) | 降血脂米粉及其制备方法 | |
CN110050847A (zh) | 一种生酮饮食和脂肪酸混合食用植物调和油 | |
JP7245399B2 (ja) | 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物 | |
TW200812569A (en) | Bone density increasing agent | |
CN1115109C (zh) | 一种全能肠内营养素及其生产方法 | |
CN1435186A (zh) | 精制海狗油在制备防治老年痴呆及中风后遗症药中的应用 | |
KR100813695B1 (ko) | Dha, dpa, epa 함량이 높은 계육생산을 위한기능성 사료첨가제를 급여하여 생산된 기능성 계육, 조리육및 가공제품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Junxiang Document name: Written notice of preliminary examination of application for patent for invention |
|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Junxiang Document name: Patent specification Addressee: Liu Junxiang Document name: patent for invention |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Liu Junxiang Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Liu Wei Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Liu Wei Document name: Notification of Decision on Request for Restoration of Right Addressee: Liu Wei Document name: Notification that Application Deemed not to be Proposed |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160127 Address after: 250002, Shandong, Ji'nan Province Shun Shun Road No. 28, Shun Geng Village, Hong Shun court 4 Patentee after: Shandong sun tree Bioengineering Co., Ltd. Address before: 100026, room four, unit 8, South Building, middle Tuanjiehu Road, Beijing, Chaoyang District, Patentee before: Liu Wei Patentee before: Liu Junxiang Patentee before: He Weijian Patentee before: Liu Yun |
|
DD01 | Delivery of document by public notice |
Addressee: Liu Junxiang Document name: Notification of Passing Examination on Formalities |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160622 Address after: Ping Pingyin County of Ji'nan City, Shandong province 250400 Street No. 15 Patentee after: Shandong Inuit biological Polytron Technologies Inc Address before: 250002, Shandong, Ji'nan Province Shun Shun Road No. 28, Shun Geng Village, Hong Shun court 4 Patentee before: Shandong sun tree Bioengineering Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050209 Termination date: 20200324 |